Soleno Therapeutics's market cap is currently $2.04B. The company's EPS TTM is $-3.314; its P/E ratio is ―; Soleno Therapeutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.97. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -1.96M	$ -2.21M	$ -2.21M	$ -2.19M	$ -2.30M
Operating Income	$ -41.38M	$ -24.40M	$ -31.53M	$ -36.29M	$ -23.49M
EBITDA	$ -37.03M	$ -21.86M	$ -28.70M	$ -30.00M	$ -28.48M
Net Income	$ -38.99M	$ -20.32M	$ -29.56M	$ -15.38M	$ -35.91M
Balance Sheet
Cash & Short-Term Investments	$ 169.68M	$ 14.60M	$ 21.30M	$ 49.22M	$ 20.73M
Total Assets	$ 180.69M	$ 26.50M	$ 35.55M	$ 64.98M	$ 38.17M
Total Debt	$ 403.00K	$ 155.00K	$ 457.00K	$ 139.00K	$ 305.00K
Net Debt	$ -169.28M	$ -14.45M	$ -20.85M	$ -49.09M	$ -20.43M
Total Liabilities	$ 23.18M	$ 16.15M	$ 17.76M	$ 19.43M	$ 23.23M
Stockholders' Equity	$ 157.51M	$ 10.35M	$ 17.79M	$ 45.55M	$ 14.95M
Cash Flow
Free Cash Flow	$ -24.94M	$ -20.79M	$ -27.79M	$ -25.23M	$ -17.40M
Operating Cash Flow	$ -24.94M	$ -20.78M	$ -27.77M	$ -25.22M	$ -17.38M
Investing Cash Flow	$ 0.00	$ -13.00K	$ -22.00K	$ -7.00K	$ 528.00K
Financing Cash Flow	$ 180.02M	$ 14.09M	$ -128.00K	$ 53.72M	$ 14.48M

Currency in USD

Soleno Therapeutics Earnings and Revenue History

Income Statement >

Soleno Therapeutics Debt to Assets

Balance Sheet >

Soleno Therapeutics Cash Flow

Cash Flow >

Soleno Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing